NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: BASF

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

BASF and Evonik Partner to Reduce the Environmental Footprint of the Feed and Animal Protein Industries - BASF and Evonik entered into an agreement, granting Evonik certain non-exclusive licensing rights to Opteinics™ - Evonik.com / BASF.com
BASF and Evonik Partner to Reduce the Environmental Footprint of the Feed and Animal Protein Industries

 

NewswireTODAY - /newswire/ - Ludwigshafen, Rhineland-Palatinate, Germany, 2022/09/20 - BASF and Evonik entered into an agreement, granting Evonik certain non-exclusive licensing rights to Opteinics™ - Evonik.com / BASF.com. Frankfurt (BAS)

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

• Global science-based companies enter up into agreement to enable transparent environmental assessment & accelerate impact reduction of the animal protein value chain;
• Cooperation combines BASF’s deep value chain sustainability experience in animal nutrition and Evonik’s extensive knowledge of feed formulation and customer insights.

BASF and Evonik entered into an agreement, granting Evonik certain non-exclusive licensing rights to Opteinics™ - BASF’s digital solution to increase understanding and reduce the environmental footprint of the feed and animal protein industries. Evonik integrates the digital ready-to-use sustainability platform Opteinics™ into its global feed consultancy services. Combining BASF's digital sustainability solution Opteinics™ with Evonik’s innovative farm management tools and sustainability services will help customers to produce more sustainable feed and animal protein.

Opteinics™ is a software solution launched by BASF in 2021 to measure, analyze and minimize the environmental impact of animal protein, with an emphasis on animal feed production. Currently the software offers modules for pig and poultry production and can be integrated with feed formulation software.

Opteinics™ for pork has recently been fully verified to conform with the ISO 14040 and 14044 LCA standards as well as with the UN Food & Agriculture Organization Livestock Environmental Assessment & Performance (LEAP) Partnership guidelines. Applications for the dairy value chain and for the optimization of compound feed mixtures will follow soon.

With the use of Opteinics™, Evonik can even better support the livestock industry to make significant progress in fighting climate change, safeguarding ecosystems, and ensuring health and well-being as it works to achieve sustainable food production.

“BASF has over 25 years of expertise in life cycle assessment. Based on our profound knowledge in sustainability improvement, we have independently developed Opteinics™. With Evonik, we have a strong partner to make it a preferred and leading solution as a digital sustainability platform for the global feed industry,” says Manuel Rez, Director Global Product Management Performance Ingredients & Solutions and Marketing BASF Animal Nutrition.

“We are incorporating BASF’s ready-to-use software Opteinics™ into our comprehensive sustainability solutions for customers,” explains Dr. Stefan Mack, head of Service Marketing at Evonik's Animal Nutrition business line. “Along with Evonik’s global sustainability feed consulting services, it will help to deliver expert knowledge, built on decades of expertise, research, and extensive data”.

BASF and Evonik are already targeting further developments in digital sustainability offerings as they both aim to help the animal production sector become more sustainable.

About BASF

At BASF (basf.com), we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. Around 111,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio comprises six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions. BASF generated sales of €78.6 billion in 2021.

About Evonik

Evonik (evonik.com) is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15 billion and an operating profit (adjusted EBITDA) of €2.38 billion in 2021. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. About 33,000 employees work together for a common purpose: We want to improve life today and tomorrow.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: BASF

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


BASF and Evonik Partner to Reduce the Environmental Footprint of the Feed and Animal Protein Industries

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Opteinics™ | BASF
Contact: Dr. Joachim Hüter - BASF.com 
+49(0) 621-60-47735 / +49(0) 172 7470917 joachim.hueter[.]basf.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any BASF securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From BASF / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ono Pharma Submits a Supplemental Application in Japan to Expand the Use of VELEXBRU® Tablets for the Treatment of Central Nervous System Involvement
Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 in Multiple System Atrophy At the 7th World Parkinson Con
Ipsen Announces Late-breaking Data from First Head-to-head Study Comparing Dysport® and Botox® in Adults with Upper Limb Spasticity
Ipsen Unveils Corabotase, A First-in-class Recombinant Neuroinhibitor, RNI™ At the SCALE Symposium
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with CartriQ® BioPure
Ojemda® Approved in The European Union as the First Targeted Therapy in Relapsed or Refractory Pediatric Low-grade Glioma
Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan
Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition
Ipsen Showcases Transformative Potential of Early Immuno-oncology Pipeline At AACR
Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology
Ono Pharma Announces Transfer of the Manufacturing and Marketing Approval Authorization for Opalmon® Tablets and Prostandin® Ointment
Ono Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory
SCHOTT Pharma Launches EVERIC® Lyo & Amber Vials for Light-sensitive ADCs
Arbitration Tribunal Upholds Ipsen’s Termination of R&D Agreement with Galderma
New Data Reinforces Ipsen’s Commitment to Bringing Solutions and Addressing Care Gaps in Neurological Diseases At TOXINS

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  Limelon Advertising, Co.





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)